期刊文献+

原发免疫性血小板减少症患者外周血调节性B细胞水平及其与病程和疗效关系的初步研究 被引量:6

Priliminary study on the number of the peripheral blood regulatory B cells in patients with primary immune throm-bocytopenia and correlation with the eoures of diease and the reponse of immunosuppressive therapy
原文传递
导出
摘要 调节悱B细胞(regulatory B cell,Breg细胞)是近年术发现的一类具有免疫调节功能的B细胞亚群。研究发现,Breg细胞存系统性红斑狼疮(SLE)、胶原诱导性关节炎、炎症性肠病等自身免疫性疾病的发病中起重要作用。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2013年第12期1055-1056,共2页 Chinese Journal of Hematology
基金 基金项目:浙汀省医药卫生科技项目(2012KYA157、2012KYA069)
  • 相关文献

参考文献7

  • 1Mizoguchi A, Bhan AK. A case for regulatory B cells. J lmmunol, 2006, 176:705-710.
  • 2DiLillo DJ, Matsushita 1", Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci, 2010, 1183:38-57.
  • 3Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol, 2008, 29:34-40.
  • 4Yang M, Sun L, Wang S, et al. Novel function of B ceil- activating factor in the induction of IL-10-producing regulatory B cells. J Immunol, 2010, 184:3321-3325.
  • 5lwata Y, Matsushita 1", Horikawa M, et al. Characterization of a rare IL-10- competent B-cell subset in humans that parallels mouse regulatory BI0 cells. Blood, 2011, 117:530-541.
  • 6无,侯明.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):975-977. 被引量:191
  • 7Blair PA, N orefia LY, Flores-Borja F, et al. CD| 9(+ )CD24 (hi) CD38 (hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity, 2010, 32:129-140.

共引文献190

同被引文献66

  • 1侯明.免疫性血小板减少症的治疗进展[J].临床血液学杂志,2020,33(1):6-9. 被引量:33
  • 2解福生,庞甲佩,刘海峰.重组人白介素-11的研究进展[J].食品与药品,2006,8(04A):9-12. 被引量:4
  • 3Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity [ J ]. Curt Opin Immunol, 2008, 20( 3 ) :332-338.
  • 4Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions [ J ]. Nature, 1974, 251( 5475 ) : 550- 551.
  • 5Mizoguehi A, Bhan AK. A case for regulatory B cells [ J ]. J Immunol, 2006, 176(2) :705-710.
  • 6Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-lO-eompetent B-cell subset in humans that parallels mouse regulatory B10 cells[ J]. Blood, 2011, 117(2) :530-541.
  • 7Blair PA, Norena LY, Flores-Borja F, et al. CD19( + ) CD24(hi) CD38(hi) B ceils exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients[J]. Immunity, 2010, 32( 1 ) :129-140.
  • 8Kessel A, Haj T, Peri R, et al. Human CD19( + )CD25(high) B regulatory cells suppress proliferation of CD4( + ) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells [ J ]. Autoimmun Rev, 2012, 11(9) :670-677.
  • 9Lindner S, Dahlke K, Sontheimer K, et al. Interleukin 21- induced granzyme B-expressing B ceils infiltrate tumors and regulate T cells[J]. Cancer Res, 2013, 73(8) :2468-2479.
  • 10Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CDldhi CD5 + phenotype controls T cell- dependent inflammatory responses [ J ]. Immunity, 2008, 28( 5 ) : 639-650.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部